1220 related articles for article (PubMed ID: 28223154)
1. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
[TBL] [Abstract][Full Text] [Related]
2. [The clinical characteristics of systemic sclerosis-related pulmonary arterial hypertension].
Wang H; Tian Z; Liu Y; Li M; Wang Q; Zeng X; Fang Q
Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):390-3. PubMed ID: 25146407
[TBL] [Abstract][Full Text] [Related]
3. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
[TBL] [Abstract][Full Text] [Related]
4. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
[TBL] [Abstract][Full Text] [Related]
5. Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension.
Hsu S; Kokkonen-Simon KM; Kirk JA; Kolb TM; Damico RL; Mathai SC; Mukherjee M; Shah AA; Wigley FM; Margulies KB; Hassoun PM; Halushka MK; Tedford RJ; Kass DA
Circulation; 2018 May; 137(22):2360-2370. PubMed ID: 29352073
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
[TBL] [Abstract][Full Text] [Related]
7. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH.
Clements PJ; Tan M; McLaughlin VV; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ; Langer A;
Ann Rheum Dis; 2012 Feb; 71(2):249-52. PubMed ID: 21998119
[TBL] [Abstract][Full Text] [Related]
8. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
[TBL] [Abstract][Full Text] [Related]
9. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
Lindholm A; Hesselstrand R; Rådegran G; Arheden H; Ostenfeld E
Clin Physiol Funct Imaging; 2019 May; 39(3):215-225. PubMed ID: 30597705
[TBL] [Abstract][Full Text] [Related]
10. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
Hofstee HM; Vonk Noordegraaf A; Voskuyl AE; Dijkmans BA; Postmus PE; Smulders YM; Serné EH
Ann Rheum Dis; 2009 Feb; 68(2):191-5. PubMed ID: 18375538
[TBL] [Abstract][Full Text] [Related]
11. Increased native T1-values at the interventricular insertion regions in precapillary pulmonary hypertension.
Spruijt OA; Vissers L; Bogaard HJ; Hofman MB; Vonk-Noordegraaf A; Marcus JT
Int J Cardiovasc Imaging; 2016 Mar; 32(3):451-9. PubMed ID: 26472581
[TBL] [Abstract][Full Text] [Related]
12. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.
Tedford RJ; Mudd JO; Girgis RE; Mathai SC; Zaiman AL; Housten-Harris T; Boyce D; Kelemen BW; Bacher AC; Shah AA; Hummers LK; Wigley FM; Russell SD; Saggar R; Saggar R; Maughan WL; Hassoun PM; Kass DA
Circ Heart Fail; 2013 Sep; 6(5):953-63. PubMed ID: 23797369
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.
Pudasaini B; Yang GL; Yang C; Guo J; Yuan P; Wen-Lan Y; Zhang R; Wang L; Zhao QH; Gong SG; Jiang R; Chen TX; Wei X; Liu JM
BMC Cardiovasc Disord; 2018 Mar; 18(1):56. PubMed ID: 29566672
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.
Xanthouli P; Jordan S; Milde N; Marra A; Blank N; Egenlauf B; Gorenflo M; Harutyunova S; Lorenz HM; Nagel C; Theobald V; Lichtblau M; Berlier C; Ulrich S; Grünig E; Benjamin N; Distler O
Ann Rheum Dis; 2020 Mar; 79(3):370-378. PubMed ID: 31818805
[TBL] [Abstract][Full Text] [Related]
15. Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.
Vos JL; Lemmers JMJ; El Messaoudi S; Snoeren M; van Dijk APJ; Duijnhouwer AL; Rodwell L; van Leuven SI; Post MC; Vonk MC; Nijveldt R
Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):708-717. PubMed ID: 38170546
[TBL] [Abstract][Full Text] [Related]
16. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
[TBL] [Abstract][Full Text] [Related]
17. Increased right atrial volume measured with cardiac magnetic resonance is associated with worse clinical outcome in patients with pre-capillary pulmonary hypertension.
Bredfelt A; Rådegran G; Hesselstrand R; Arheden H; Ostenfeld E
ESC Heart Fail; 2018 Oct; 5(5):864-875. PubMed ID: 29916558
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis.
Lefèvre G; Dauchet L; Hachulla E; Montani D; Sobanski V; Lambert M; Hatron PY; Humbert M; Launay D
Arthritis Rheum; 2013 Sep; 65(9):2412-23. PubMed ID: 23740572
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population.
Hinchcliff M; Fischer A; Schiopu E; Steen VD;
J Rheumatol; 2011 Oct; 38(10):2172-9. PubMed ID: 21844142
[TBL] [Abstract][Full Text] [Related]
20. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
